Equillium, Inc.
Equillium, Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 57 | 61 | 30 | 33 | 11 | 15 | 18 | 15 | 11 | 12 | 23 | 34 | |||||
Available For Sale Securities Debt Securities Curr… | - | - | - | 0 | 0 | 0 | 4 | 10 | 22 | 21 | 18 | 12 | |||||
Prepaid Expense And Other Assets Current | 1 | 1 | 1 | 0 | 0 | 2 | 2 | 3 | 3 | 5 | 5 | 4 | |||||
Accounts Receivable Net Current | - | - | - | - | - | - | 0 | 5 | 6 | 5 | 4 | 4 | |||||
Assets Current | 58 | 62 | 31 | 34 | 12 | 16 | 25 | 34 | 42 | 42 | 49 | 54 | |||||
Operating Lease Right Of Use Asset | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | |||||
Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Other Assets Noncurrent | 0 | 0 | 0 | - | - | - | - | 0 | 0 | 0 | 0 | 0 | |||||
Assets | 59 | 63 | 32 | 35 | 12 | 17 | 26 | 34 | 43 | 44 | 51 | 55 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 1 | 1 | 1 | 1 | 5 | 3 | 3 | 4 | 4 | 3 | 5 | 4 | |||||
Accrued Liabilities Current | 1 | 2 | 2 | 2 | 2 | 3 | 3 | 5 | 7 | 6 | 7 | 8 | |||||
Deferred Revenue Current | - | - | - | - | - | - | - | 2 | 8 | 13 | 16 | 16 | |||||
Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities Current | 2 | 3 | 3 | 3 | 7 | 6 | 6 | 11 | 20 | 22 | 28 | 28 | |||||
Deferred Revenue Noncurrent | - | - | - | - | - | - | - | - | - | - | - | 2 | |||||
Operating Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities | 3 | 4 | 3 | 4 | 7 | 6 | 7 | 11 | 20 | 23 | 28 | 31 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital Common Stock | 282 | 281 | 244 | 243 | 213 | 212 | 212 | 211 | 210 | 209 | 208 | 207 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | 0 | 0 | 0 | 0 | 0 | 1 | 1 | -0 | 0 | 0 | 0 | 0 | |||||
Retained Earnings Accumulated Deficit | -226 | -222 | -216 | -212 | -208 | -202 | -194 | -188 | -188 | -188 | -186 | -183 | |||||
Stockholders Equity | 56 | 59 | 29 | 31 | 5 | 11 | 19 | 23 | 22 | 21 | 23 | 24 | |||||
Liabilities And Stockholders Equity | 59 | 63 | 32 | 35 | 12 | 17 | 26 | 34 | 43 | 44 | 51 | 55 | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Authorized | 400 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | |||||
Common Stock Shares Issued | 63 | 63 | 61 | 61 | 36 | 36 | 36 | 35 | 35 | 35 | 35 | 35 | |||||
Shares Outstanding | 63 | 63 | 61 | 61 | 36 | 36 | 36 | 35 | 35 | 35 | 35 | 35 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 27.27% | 25.97% | 0.43% | - | - | - | - | - | - | - | - | - |
| 2025 | 2.70% | -13.51% | 91.89% | 94.90% | 35.71% | 43.88% | 1.19% | 82.14% | 69.05% | -0.49% | 5.83% | 36.41% |
| 2024 | -16.67% | -61.67% | -54.44% | 50.70% | 16.90% | 66.20% | -6.41% | 0.00% | -17.95% | -4.08% | -24.49% | -28.57% |
| 2023 | - | - | - | - | - | - | 6.00% | 44.00% | 70.00% | -34.02% | -36.07% | -70.90% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 23.40 | 18.62 | 10.58 | 10.85 | 1.65 | 2.70 | 3.93 | 3.04 | 2.08 | 1.91 | 1.79 | 1.91 | |||||
| Quick Ratio | 23.07 | 18.33 | 10.32 | 10.70 | 1.59 | 2.42 | 3.55 | 2.79 | 1.94 | 1.68 | 1.62 | 1.78 | |||||
| Working Capital | 55.50M | 58.93M | 28.10M | 30.49M | 4.72M | 10.21M | 18.62M | 22.59M | 21.72M | 20.27M | 21.78M | 25.71M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.05 | 0.06 | 0.12 | 0.12 | 1.45 | 0.58 | 0.34 | 0.49 | 0.91 | 1.07 | 1.24 | 1.29 | |||||
| Interest Coverage TTM | - | - | - | - | - | - | - | - | -19.78 | -17.61 | -14.79 | -5.25 | |||||
| Debt Ratio | 0.05 | 0.06 | 0.10 | 0.10 | 0.59 | 0.37 | 0.26 | 0.33 | 0.48 | 0.52 | 0.55 | 0.56 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.00 | 0.00 | 0.00 | 0.13 | 0.60 | 1.01 | 1.08 | 1.02 | 0.84 | 0.66 | 0.56 | 0.52 | |||||
| Days Sales Outstanding TTM | - | - | - | - | - | - | - | 34.89 | 41.26 | 40.80 | 33.24 | 51.19 | |||||
| Receivables Turnover TTM | - | - | - | - | - | - | - | 10.46 | 8.85 | 8.95 | 10.98 | 7.13 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -0.16 | -0.20 | -0.39 | -0.37 | -0.57 | -0.39 | -0.23 | -0.13 | -0.23 | -0.34 | -0.38 | -0.24 | |||||
| Free Cash Flow Per Share TTM | -0.21 | -0.20 | -0.40 | -0.23 | -0.39 | -0.52 | -0.54 | -0.61 | -0.45 | -0.64 | -0.63 | 0.33 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Operating Profit Margin TTM | - | - | - | -554.92% | -123.70% | -47.19% | -20.12% | -14.74% | -22.79% | -34.85% | -40.24% | -34.53% | |||||
| Net Profit Margin TTM | - | - | - | -555.94% | -122.00% | -46.00% | -19.63% | -10.05% | -19.52% | -32.01% | -36.96% | -30.59% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | -100.00% | -100.00% | -100.00% | -90.43% | -61.16% | -19.76% | 13.89% | 70.86% | 136.75% | 326.78% | - | - | |||||
| Net Income Growth (1Y) | -10.82% | 36.23% | 177.65% | 429.08% | 142.77% | 15.32% | -39.51% | -43.86% | -54.21% | -58.11% | -78.64% | -89.16% | |||||
| EPS Growth (1Y) | -71.51% | -49.65% | 71.31% | 186.92% | 139.87% | 14.24% | -40.59% | -44.72% | -55.30% | -59.10% | -79.25% | -89.32% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -19.87 | -10.11 | -3.97 | -3.83 | -0.57 | -0.99 | -3.29 | -6.37 | -2.93 | -6.71 | -1.87 | -3.14 | |||||
| P/B TTM | 6.39 | 3.24 | 3.11 | 3.02 | 2.26 | 1.31 | 1.39 | 1.27 | 1.09 | 3.86 | 1.11 | 1.07 | |||||
| P/S TTM | - | - | - | 21.27 | 0.69 | 0.46 | 0.65 | 0.64 | 0.57 | 2.15 | 0.69 | 0.96 | |||||
| Market Cap | 357.78M | 192.56M | 88.82M | 93.41M | 11.43M | 13.88M | 26.52M | 29.40M | 24.35M | 81.44M | 25.00M | 25.81M | |||||
| Enterprise Value | 300.61M | 131.24M | 58.54M | 60.29M | -64.82K | -623.12K | 8.43M | 13.95M | 13.29M | 69.87M | 1.79M | -8.57M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -23.96M | -18.93M | -22.80M | -14.76M | -13.98M | -18.47M | -19.11M | -21.51M | -15.77M | -22.66M | -21.83M | 11.59M | |||||
| Net Debt | -57.16M | -61.32M | -30.28M | -33.12M | -11.50M | -14.50M | -18.09M | -15.45M | -11.06M | -11.57M | -23.22M | -34.38M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
Equillium, Inc. (EQ) — SEC Financial Statements & Analysis
Equillium, Inc. (EQ) is a pharmaceutical preparations company, incorporated in DE. Equillium, Inc. trades on Nasdaq as: EQ. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Equillium, Inc. reported a -100.00% year-over-year revenue growth, a Debt-to-Equity ratio of 0.05x, a Price-to-Sales (P/S) ratio of 21.27x (TTM), a Price-to-Book (P/B) ratio of 6.39x (TTM), at a market cap of $357.78M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -100.00%
- Debt To Equity
- 0.05x
- P/S TTM
- 21.27x
- P/B TTM
- 6.39x
- Market Cap
- $357.78M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Equillium, Inc. in?
Equillium, Inc. (EQ) operates in the Pharmaceutical Preparations industry.
What is EQ's market cap?
Equillium, Inc. (EQ) has a market capitalization of $357.78M as of 2026-06-30.
What exchange does EQ trade on?
Equillium, Inc. (EQ) trades on the Nasdaq.
Where is Equillium, Inc. incorporated?
Equillium, Inc. is incorporated in DE.